Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Recruiting now · Not applicable

Conditions studied: Prostate Cancer Patients Treated by Radiotherapy

In brief

This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.

Key facts

Study ID
NCT07130682
Run by
Hong Kong Sanatorium & Hospital
People needed
35
Starts
2025-09-01
Expected to finish
2033-06-02
Last updated by the study team
2026-03-16

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.